Emmaus Life Sciences, Inc. (EMMA) Reports Q2 Loss of $0.02

Emmaus Life Sciences, Inc. (OTC: EMMA) reported Q2 EPS of ($0.02). Revenue for the quarter came in at $2.82 million.

For earnings history and earnings-related data on Emmaus Life Sciences, Inc. (EMMA) click here.

You May Also Be Interested In

• Altman: AI Has More Of A Science Problem Than Engineering
• AAR Corporation (AIR) PT Raised to $160 at Jefferies
• OpenAI annual recurring revenue approaches $70B mark - Axios